Wei Tse Yang
Breast Imaging Section Editor
Wei Tse Yang, MBBS, FRCR, is the Robert D. Moreton Distinguished Chair in the Department of Breast Imaging at the University of Texas MD Anderson Cancer Center. She is Medical Director, Quantitative Imaging Analysis Core and Chair, Imaging Response Assessment Team for execution of Response Evaluation Criteria in Solid Tumors (RECIST) measurements to support clinical trial development and drug discovery. Her special research interests include functional (optoacoustic) ultrasound for the measurement of tumor response, and co‐developing the multidisciplinary technique of “targeted axillary dissection”, which ensures a false negative rate of less than 5% for sentinel lymph node dissection in breast cancer patients after neoadjuvant chemotherapy. She is Co‐PI in a protocol that aims to eliminate surgery for breast cancer patients who are exceptional responders to neoadjuvant chemotherapy. An advocate of the Divisional Council of Gender Inclusiveness Committee, and the Women Faculty and Minority Inclusion Group at MD Anderson, she is passionate about supporting academic growth of women and minority teams.
Dr. Yang has authored and co‐authored more than 200 peer‐reviewed articles and book chapters. She has served on the editorial board of the American Journal of Roentgenology (AJR), and was a co‐lead author of the Diagnostic Imaging: Breast textbook (2nd Edition).
Dr. Yang earned her MBBS from National University of Singapore, and received board certification in Diagnostic Radiology from the United Kingdom (FRCR, London), Hong Kong (FHKCR), and the United States of America (ABR). She is a fellow of the Society of Breast Imaging and a Fellow of the American College of Radiology. She will graduate from Johns Hopkins University with her MSc Healthcare Management in May 2020.
Disclosures: Dr. Yang reports personal fees from Elsevier.